The size of the Sterile Filtration Market in North America is estimated to grow USD 2.46 billion in 2022. It is forecasted to be growing at a CAGR of 13.56% and worth USD 4.65 billion by 2027.
The benefits of sterile filters over non-sterile filters, the growing need for pure water in the end-user market, the increasing acceptance of single-use technologies, and the increased focus on developing big biopharmaceutical medicines are the key drivers driving the North American sterile filtration market. Furthermore, the release of large concentrations of antibiotics on industrial sites may result in new diseases. As a result, filtering plays a significant role in medication development. However, to guarantee patient safety, the medicines must be safeguarded against the entry of undesirable bacteria, viruses, and other microorganisms.
The growing number of research efforts for the development of sophisticated fillers and the rising number of applications from emerging economies are the main drivers of growth. In addition, the sterile filtration market is expected to increase in response to rising pharmaceutical spending and the growing prevalence of chronic and acute illnesses. Furthermore, during the forecast period, rising R&D and increased demand for strong medicines may be regarded as significant market drivers.
Growth in the biopharmaceutical sector, rising demand for pharmaceutical molecules, rising prevalence of diabetes and renal failure, and rising purity requirements among end-users are some of the main reasons expected to propel the sterile filtration market forward. Growing public health concerns and regulatory toughening, combined with ongoing technological advancements in the filtration equipment market, are transforming the pharmaceutical and food & beverage industries in emerging markets, moving them away from the traditional filtration methods and modern, sophisticated filtration methods. In the medical industry, sterile filtration can be accomplished via microfiltration employing membrane filtration for pharmaceutical and protein solutions. The goals of sterile filtration are to ensure the safety of patients and users and reduce patient risk.
The sterile filtration market's expansion in North America is expected to be hampered by the market's stringent rules and regulations. In addition, the sterile filtration market is anticipated to be hampered by factors such as rigorous regulatory standards for filtering process validation and the high capital expenditure required to start up a new production unit. The high initial capital investment, R&D costs, and human resources required to add additional cost for pharmaceutical, biotechnological products, and compliance of these Sterile Filtration products in a vast and heterogeneous market are the major challenges for the market.
This research report on the North America Sterile Filtration Market has been segmented and sub-segmented into the following categories:
By Membrane Pore Size:
By End User:
As of 2020, North America leads the global sterile filtration market accounting for more than 34% of the entire market share. The increased government funding focused on enhancing the filtration facility is the prime growth driver for this region's market. In addition, because of the growing number of API production facilities and firms' increased R&D activities, North America is projected to be a leading area in the Sterile Filtration market. The North American region's high share may be ascribed to the region's huge number of pharmaceutical, biotechnology, and food & beverage firms, rise in the incidence of chronic illnesses such as diabetes, renal disease, cancer, and heart issues, as well as the presence of a well-established healthcare sector and rigorous pharmaceutical regulations.
KEY MARKET PLAYERS:
Some prominent companies in the North American Sterile filtration market include Merck & Co., Inc., 3M, General Electric Company, Pall Corporation, Parker Hannifin Corporation, Sartorius Stedim Biotech Group, Porvair Filtration Group, Sterlitech Corporation, and Starlab Scientific Co., Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com